Literature DB >> 15955856

Treatment of hepatic venous outflow obstruction after piggyback liver transplantation.

Stephen L Wang1, Daniel Y Sze, Stephan Busque, Mahmood K Razavi, Stephen T Kee, Joan K Frisoli, Michael D Dake.   

Abstract

PURPOSE: To evaluate retrospectively the endovascular management of hepatic venous outflow obstruction after piggyback orthotopic liver transplantation.
MATERIALS AND METHODS: The study was performed with the approval and under the guidelines of the institutional review board and complied with the Health Insurance Portability and Accountability Act. Informed consent from patients was not required by the institutional review board for this retrospective study. From 1995 to 2003, 13 patients (eight male, five female), including 12 adults and one adolescent (age range, 14-67 years; median age, 52 years), underwent endovascular treatment of hepatic venous outflow obstruction after piggyback orthotopic liver transplantation. Patients gave informed consent for all procedures. Eleven patients received whole livers, and two received living-related donor right liver lobes. Four underwent repeat piggyback orthotopic liver transplantation prior to intervention. Primary stent placement was performed in 12 patients. One patient refused primary stent placement and chose venoplasty alone, but required a stent 5 months later. Short balloon-expandable stents (mean diameter, 14.6 mm +/- 1.1 [standard deviation]) were used to minimize jailing of branch vessels and to resist recoil. Pre- and post-procedural pressure gradients were measured. Follow-up included venography, cross-sectional imaging, and laboratory tests. The Wilcoxon signed rank test or the sign test was performed to compare pre- and post-procedural pressure gradients, body weights, and laboratory values.
RESULTS: Technical success (pressure gradient < or = 3 mm Hg) was achieved in 13 of 13 patients, and clinical success, in 12 of 13. Mean pre- and post-procedural pressure gradients were 13.0 mm Hg +/- 1.4 and 0.8 mm Hg +/- 0.3. Mean interval from transplantation to intervention was 348 days +/- 159. Mean follow-up was 678 days (range, 16-2880 days). Technical success did not result in clinical improvement in one patient. Biopsy demonstrated severe hepatic necrosis, likely from prolonged venous congestion, and the patient required repeat transplantation. Only one patient required reintervention for stent migration, and no other complications occurred. No significant restenosis was encountered after stent placement.
CONCLUSION: Hepatic venous outflow obstruction is an uncommon but potentially fatal complication of piggyback orthotopic liver transplantation. Endovascular treatment with balloon-expandable stents is effective, safe, and apparently durable. Copyright RSNA, 2005

Entities:  

Mesh:

Year:  2005        PMID: 15955856     DOI: 10.1148/radiol.2361040327

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

Review 1.  Vascular complications following liver transplantation: A literature review of advances in 2015.

Authors:  Tullio Piardi; Martin Lhuaire; Onorina Bruno; Riccardo Memeo; Patrick Pessaux; Reza Kianmanesh; Daniele Sommacale
Journal:  World J Hepatol       Date:  2016-01-08

2.  Endovascular treatment with primary stenting of inferior cava vein torsion following orthotopic liver transplantation with modified piggyback technique.

Authors:  Carlo Ferro; Enzo Andorno; Andrea Guastavino; Umberto G Rossi; Sara Seitun; Giulio Bovio; Umberto Valente
Journal:  Radiol Med       Date:  2013-12-20       Impact factor: 3.469

3.  Budd-Chiari syndrome after liver transplantation resulting from inferior vena cava occlusion at the suture line.

Authors:  Saima Karim; Mohammad M Karim; Victor Lucas; Anil Verma; Nigel Girgrah; Stephen Ramee
Journal:  J Cardiol Cases       Date:  2015-01-06

4.  Chronic diarrhea, ascites, and protein-losing enteropathy in an infant with hepatic venous outflow obstruction after liver transplantation.

Authors:  S K Hourigan; R A Anders; S E Mitchell; K B Schwarz; H Lau; W Karnsakul
Journal:  Pediatr Transplant       Date:  2012-04-10

5.  Percutaneous transluminal venoplasty after venous pressure measurement in patients with hepatic venous outflow obstruction after living donor liver transplantation.

Authors:  Osamu Ikeda; Yoshitaka Tamura; Yutaka Nakasone; Yasuyuki Yamashita; Hideaki Okajima; Katsuhiro Asonuma; Yukihiro Inomata
Journal:  Jpn J Radiol       Date:  2010-08-27       Impact factor: 2.374

6.  Utility of liver biopsy in predicting clinical outcomes after percutaneous angioplasty for hepatic venous obstruction in liver transplant patients.

Authors:  Ammar Sarwar; Edward Ahn; Ian Brennan; Olga R Brook; Salomao Faintuch; Raza Malik; Khalid Khwaja; Muneeb Ahmed
Journal:  World J Hepatol       Date:  2015-07-18

Review 7.  [Complication management after liver transplantation. Increasing patient safety by standardized approach and interdisciplinary cooperation].

Authors:  P Houben; D N Gotthardt; B Radeleff; P Sauer; M W Büchler; P Schemmer
Journal:  Chirurg       Date:  2015-02       Impact factor: 0.955

8.  Does clamping during liver surgery predispose to thrombosis of the hepatic veins? Analysis of 210 cases.

Authors:  Nikolaos Arkadopoulos; Vaia Stafyla; Athanasios Marinis; Vassilios Koutoulidis; Kassiani Theodoraki; Theodosios Theodosopoulos; Ioannis Vassiliou; Nikolaos Dafnios; Georgios Fragulidis; Vassilios Smyrniotis
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

9.  Successful recanalization of occluded intrahepatic inferior vena cava in post-liver transplant Budd-Chiari syndrome.

Authors:  Deepak Garg; Jorge Enrique Lopera
Journal:  Indian J Gastroenterol       Date:  2013-03-10

Review 10.  Interventional radiology procedures in adult patients who underwent liver transplantation.

Authors:  Roberto Miraglia; Luigi Maruzzelli; Settimo Caruso; Mariapina Milazzo; Gianluca Marrone; Giuseppe Mamone; Vincenzo Carollo; Salvatore Gruttadauria; Angelo Luca; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.